Our mission.
Our mission is to preserve brain function and protect quality of life - so that people can live longer, fuller, and happier lives.
Today, over 12 million people worldwide are living with Parkinson’s disease, a progressive neurodegenerative disorder that affects movement, cognition, mood, and independence - with no available treatment that can stop or reverse its progression.
Parkinson’s is just one part of the growing burden of neurodegeneration. An estimated 55 million people are currently living with dementia, including Alzheimer’s disease and frontotemporal dementia, and tens of thousands more are affected by diseases like Huntington’s disease. All of these diseases share a common feature: the progressive loss of nerve cells that leads to irreversible decline in daily functions.
.png)
Happiness begins in the brain — and we are committed to keeping it strong and protected.
We envision a world where neurodegenerative diseases no longer define a person’s future - a world where brains stay resilient, and people retain the moments, movement, and memories that matter most.
Our approach is rooted in scientific innovation. By developing novel peptide therapeutics that activate the brain’s natural survival pathways, we aim to slow or halt neurodegeneration at the cellular level. Our therapies are designed to enhance neuronal resilience and preserve brain function - starting with Parkinson’s disease.
